Torrey Coast Foundation
Total Giving
$6.6M
Number of Grants
15
Median Grant
$247K
Grant Range
$46K - $1.5M
Year | Assets | Total Giving | # Grants | Median Grant |
---|---|---|---|---|
2023 | $303.4M | $6.6M | 15 | $247K |
2022 | $121K | $2.9M | 10 | $280K |
CASE WESTERN RESERVE UNIVERSITY
COLLABORATION WITH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND COLUMBIA UNIVERSITY'S GI ONCOLOGY TEAMS.
10900 EUCLID AVENUE - CLEVELAND - OH 44106 β’ 2022
$46K
COLUMBIA UNIVERSITY
FOR CENTRALIZING GASTROESOPHAGEAL CANCER RESOURCES GIFT FUND, GRANT PROPOSAL" GENERATING GASTROESOPHAGEAL TUMOR TISSUE MICROARRAYTS", TO ESTABLISH THE TORREY COAST STRATEGIC RESEARCH FUND, WHICH SHALL BE USED TO SUPPORT GASTRIC AND ESOPHAGEAL CANCER RESEARCH, TO CONDUCT THE SCIENCE DESCRIBED IN DR. WANG AND BASS'S PROPOSAL,"TARGETING MYELOID CELLS TO ENHANCE IMMUNOTHERAPY TARGETING T CELLS", AND FOR GRANT PROPOSAL" GENERATING GASTROESOPHAGEAL TUMOR TISSUE MICROARRAYTS".
630 WEST 168TH STREET - NEW YORK - NY 10032 β’ 2022
$1.0M
CORNELL UNIVERSITY - THE JOAN AND SANFORD I WEILL MEDICAL COLLEGE
TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH TO GENERATE INFORMATION ON THE MECHANISMS OF "DIFFUSE" MESENCHYMAL TYPE OF GASTRIC CANCER AND TO PROMOTE AND ENHANCE THE WORK OF THE MEDICAL COLLEGE THROUGH THE SUPPORT OF RESEARCH IN IDENTIFYING AND TESTING EVIDENCE-BASED TARGETED THERAPEUTIC STRATEGIES IN GASTRIC CANCER: TARGETING TGF AND THE IMMUNE MICROENVIRONMENT.
1300 YORK AVENUE - NEW YORK - NY 10065 β’ 2022
$575K
EMORY UNIVERSITY SCHOOL OF MEDICINE
FOR GRANT PROPOSAL" ADENOSQUAMOUS CARCINOMAS OF THE ESOPHAGUS: UNIQUE BIOLOGICAL AND THERAPEUTIC INSIGHTS FROM A RARE CANCER".
201 DOWMAN DR - ATLANTA - GA 30322 β’ 2022
$77K
HIAS INC
TO SUPPORT UKRANIAN REFUGEES SEEKING SAFETY IN JEWISH COMMUNITIES IN EUROPE.
1300 SPRING ST STE 500 - SILVER SPRING - MD 20910 β’ 2022
$100K
INSITITUE OF MOLECULAR CELL BIOLOGY
FOR GRANT PROPOSAL "EVALUATING GASTRIC CANCER THERAPEUTICS IN OUR CLDN18-ATK GENETICALLY ENGINEERED MOUSE MODEL OF GASTRIC CANCER".
55 FRUIT STREET - BOSTON - MA 02114 β’ 2022
$247K
MASSACHUSETTES GENERAL HOSPITAL
TO SUPPORT RSEARCH INCLUDING, BUT NOT LIMITED TO, EX-VIVO SENSITIVITY TESTING, BIOSENSOR EFFORTS, AND IDENTIFICATION OF DRUG AGENTS TO GENERATE CLINICAL TRIAL PILOT DATA IN REGARDS TO THE TREATMENTS OF ESOPHAGOGASTRIC CANCER
1275 YORK AVENUE - NEW YORK - NY 10065 β’ 2022
$101K
MEMORIAL SLOAN-KETTERING CANCER CENTER
TO ORGANIZE RESEARCH IN ESOPHAGOGASTRIC CANCER UNDER THE DIRECTION OF DRS. YELENA JANJIGIAN AND KARUNA GANESH.
96 CALIFORNIA INSTITUTE OF - PASADENA - CA 91106 β’ 2022
$396K
THE BROAD INSTITUTE INC
FOR THE PROJECT, ADAPTING 3D CANCER ORGANOIDS INTO MONOLAYER CELL LINES TO EXPAND MODEL UTILIZATION AND FOR SCREENING COMPOUNDS USING THE PRISM SCREENING PLATFORM.
120 BROADWAY - NEW YORK - NY 10271 β’ 2022
$513K
THE DEGREGORIO FAMILY FOUNDATION
TO SUPPORT THE COLLABORATIVE RSERACH GRANTS FUNDED FOR GASTRIC AND ESOPHAGEAL CANCER RESEARCH,
10880 WILSHIRE BLVD STE 1400 - LOS ANGELES - CA 90024 β’ 2022
$375K
Location
CaliforniaReturn Type
990PF
Most Recent Filing
2023
Annual Expenses
$11.7M
Giving Rate
2.2% of assets
Accepts Applications